308 related articles for article (PubMed ID: 8607275)
1. Increased transcomplementation properties of plasmids carrying HSV-1 origin of replication and packaging signals.
Berthomme H; Fournel S; Epstein AL
Virology; 1996 Feb; 216(2):437-43. PubMed ID: 8607275
[TBL] [Abstract][Full Text] [Related]
2. The essential in vivo function of the herpes simplex virus UL42 protein correlates with its ability to stimulate the viral DNA polymerase in vitro.
Reddig PJ; Grinstead LA; Monahan SJ; Johnson PA; Parris DS
Virology; 1994 May; 200(2):447-56. PubMed ID: 8178434
[TBL] [Abstract][Full Text] [Related]
3. Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome.
Saeki Y; Fraefel C; Ichikawa T; Breakefield XO; Chiocca EA
Mol Ther; 2001 Apr; 3(4):591-601. PubMed ID: 11319922
[TBL] [Abstract][Full Text] [Related]
4. Combined HSV-1 recombinant and amplicon piggyback vectors: replication-competent and defective forms, and therapeutic efficacy for experimental gliomas.
Pechan PA; Herrlinger U; Aghi M; Jacobs A; Breakefield XO
J Gene Med; 1999; 1(3):176-85. PubMed ID: 10738566
[TBL] [Abstract][Full Text] [Related]
5. Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: rescue of replication-competent virus progeny and packaging of amplicon vectors.
Saeki Y; Ichikawa T; Saeki A; Chiocca EA; Tobler K; Ackermann M; Breakefield XO; Fraefel C
Hum Gene Ther; 1998 Dec; 9(18):2787-94. PubMed ID: 9874276
[TBL] [Abstract][Full Text] [Related]
6. Analysis of in vitro activities of herpes simplex virus type 1 UL42 mutant proteins: correlation with in vivo function.
Thornton KE; Chaudhuri M; Monahan SJ; Grinstead LA; Parris DS
Virology; 2000 Sep; 275(2):373-90. PubMed ID: 10998337
[TBL] [Abstract][Full Text] [Related]
7. Optimal purification method for Herpes-based viral vectors that confers minimal cytotoxicity for systemic route of vector administration.
Sia KC; Wang GY; Ho IA; Khor HY; Miao L; Hui KM; Lam PY
J Virol Methods; 2007 Feb; 139(2):166-74. PubMed ID: 17074404
[TBL] [Abstract][Full Text] [Related]
8. An HSV-1 amplicon system for prostate-specific expression of ICP4 to complement oncolytic viral replication for in vitro and in vivo treatment of prostate cancer cells.
Lee CY; Bu LX; Rennie PS; Jia WW
Cancer Gene Ther; 2007 Jul; 14(7):652-60. PubMed ID: 17479106
[TBL] [Abstract][Full Text] [Related]
9. Construction and packaging of herpes simplex virus/adeno-associated virus (HSV/AAV) Hybrid amplicon vectors.
Saydam O; Glauser DL; Fraefel C
Cold Spring Harb Protoc; 2012 Mar; 2012(3):352-6. PubMed ID: 22383640
[TBL] [Abstract][Full Text] [Related]
10. Assembly of complete, functionally active herpes simplex virus DNA replication compartments and recruitment of associated viral and cellular proteins in transient cotransfection assays.
Zhong L; Hayward GS
J Virol; 1997 Apr; 71(4):3146-60. PubMed ID: 9060678
[TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
[TBL] [Abstract][Full Text] [Related]
12. Improved packaging system for generation of high-level noncytotoxic HSV-1 amplicon vectors using Cre-loxP site-specific recombination to delete the packaging signals of defective helper genomes.
Zaupa C; Revol-Guyot V; Epstein AL
Hum Gene Ther; 2003 Jul; 14(11):1049-63. PubMed ID: 12885345
[TBL] [Abstract][Full Text] [Related]
13. Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap.
Conway JE; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
J Virol; 1997 Nov; 71(11):8780-9. PubMed ID: 9343238
[TBL] [Abstract][Full Text] [Related]
14. Gene delivery using helper virus-free HSV-1 amplicon vectors.
Fraefel C
Curr Protoc Hum Genet; 2002 Aug; Chapter 12():Unit 12.12. PubMed ID: 18428323
[TBL] [Abstract][Full Text] [Related]
15. Generation of high-titer defective HSV-1 vectors.
Lim F; Neve RL
Curr Protoc Neurosci; 2001 May; Chapter 4():Unit 4.13. PubMed ID: 18428477
[TBL] [Abstract][Full Text] [Related]
16. A modular set of helper-dependent herpes simplex virus expression vectors.
Strathdee CA; McLeod MR
Mol Ther; 2000 May; 1(5 Pt 1):479-85. PubMed ID: 10933969
[TBL] [Abstract][Full Text] [Related]
17. Herpes simplex virus type 1 recombinants without the oriL sequence replicate DNA with increased fidelity.
Jiang C; Hwang YT; Hwang CB
Virology; 2006 Apr; 347(2):277-85. PubMed ID: 16427677
[TBL] [Abstract][Full Text] [Related]
18. Engineering cell lines for production of replication defective HSV-1 gene therapy vectors.
Grant KG; Krisky DM; Ataai MM; Glorioso JC
Biotechnol Bioeng; 2009 Mar; 102(4):1087-97. PubMed ID: 18828174
[TBL] [Abstract][Full Text] [Related]
19. Establishment of a novel foreign gene delivery system combining an HSV amplicon with an attenuated replication-competent virus, HSV-1 HF10.
Zhang L; Daikoku T; Ohtake K; Ohtsuka J; Nawa A; Kudoh A; Iwahori S; Isomura H; Nishiyama Y; Tsurumi T
J Virol Methods; 2006 Nov; 137(2):177-83. PubMed ID: 16854473
[TBL] [Abstract][Full Text] [Related]
20. Genetic engineering of herpes simplex virus and vector genomes carrying loxP sites in cells expressing Cre recombinase.
Logvinoff C; Epstein AL
Virology; 2000 Feb; 267(1):102-10. PubMed ID: 10648187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
